1800-272-662
Shopping Cart 0
countryflagAU
Login

Renergen Ltd

Energy AU RLT

NoneAUD
-(-%)

Last update at 2026-02-12T06:45:05.154002Z

Day Range

--
LowHigh

52 Week Range

0.321.50
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap116.38M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-198.29501M
  • Revenue TTM55.60M
  • Revenue Per Share TTM0.38
  • Gross Profit TTM -92.36600M
  • Diluted EPS TTM-0.18

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-02-28 2024-02-29 2023-02-28 2022-02-28 2021-02-28
Type yearly yearly yearly yearly yearly
Date 2025-02-28 2024-02-29 2023-02-28 2022-02-28 2021-02-28
Income before tax -298.07900M -146.99100M -36.43200M -42.30300M -50.79200M
Minority interest 10.81M - - - -2.64500M
Net income -236.12000M -110.27300M -26.72500M -33.75000M -42.62000M
Selling general administrative 37.27M - 9.74M 7.96M 7.63M
Selling and marketing expenses 10.94M - 5.22M 1.07M -
Gross profit -28.06000M 10.07M 4.00M -0.77500M -0.91700M
Reconciled depreciation 62.56M - 5.41M 5.52M 4.74M
Ebit -216.96000M -135.09700M -31.90400M -38.08600M -46.56100M
Ebitda -154.40300M -114.38900M -26.49200M -32.56600M -41.81700M
Depreciation and amortization 62.56M 20.71M 5.41M 5.52M 4.74M
Non operating income net other - - - - -
Operating income -227.74400M -135.09700M -35.52400M -38.36100M -46.77300M
Other operating expenses 279.86M 164.05M 61.76M 44.57M 40.39M
Interest expense 81.12M - 4.58M 4.22M 4.69M
Tax provision -51.15100M - -9.70700M -8.55300M -8.17200M
Interest income 10.78M - 3.37M 0.28M 0.67M
Net interest income -70.33500M - -0.90800M -3.94200M -4.01900M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -51.15100M 37.20M -9.70700M -8.55300M -8.17200M
Total revenue 52.11M 28.95M 12.69M 2.64M 1.93M
Total operating expenses 199.68M 145.16M 53.08M 41.16M 37.54M
Cost of revenue 80.17M 18.89M 8.68M 3.41M 2.84M
Total other income expense net -70.33500M -11.89400M -0.90800M -3.94200M -4.01900M
Discontinued operations - - - - -
Net income from continuing ops -246.92800M - -26.72500M -33.75000M -42.62000M
Net income applicable to common shares -236.12000M - -26.72500M -33.75000M -42.62000M
Preferred stock and other adjustments - - - - -
Breakdown 2025-02-28 2024-02-29 2023-02-28 2022-02-28 2021-02-28
Type yearly yearly yearly yearly yearly
Date 2025-02-28 2024-02-29 2023-02-28 2022-02-28 2021-02-28
Total assets 2349.17M 2709.13M 1900.88M 1164.69M 780.36M
Intangible assets 24.30M 82.21M 24.41M 16.89M 3.16M
Earning assets - - - - -
Other current assets 73.20M 87.30M - - 16.14M
Total liab 1234.57M 1388.02M 1060.68M 878.38M 573.95M
Total stockholder equity 1038.63M 1243.65M 840.20M 286.31M 206.41M
Deferred long term liab - - - 13.00M -
Other current liab 26.21M 1.81M 23.64M 16.65M 25.50M
Common stock 1210.30M 1170.06M 1134.75M 563.88M 453.08M
Capital stock 1210.30M - 1134.75M 563.88M 453.08M
Retained earnings -198.93400M 46.52M -316.24300M -289.51800M -255.76800M
Other liab - - - - 4.00M
Good will - - - - -
Other assets - - - 60.26M 37.86M
Cash 28.32M 471.07M 55.70M 95.09M 130.88M
Cash and equivalents - - - - 130.88M
Total current liabilities 1111.92M 571.56M 200.35M 74.43M 32.48M
Current deferred revenue - - - - -
Net debt 1050.40M 776.67M 857.60M 730.93M 409.61M
Short term debt 1015.51M 487.47M 105.64M 51.56M 3.01M
Short long term debt 1013.74M - 104.46M 49.78M -
Short long term debt total 1078.72M 1247.74M 913.31M 826.02M 540.48M
Other stockholder equity 27.26M 0.00000M 21.70M 11.95M 9.10M
Property plant equipment - - - - 475.56M
Total current assets 113.15M 599.13M 171.53M 156.38M 154.79M
Long term investments - - - - -
Net tangible assets - - - 145.28M 94.25M
Short term investments 2.14M - - - 0.00000M
Net receivables 8.44M 38.68M 8.80M 27.02M 7.59M
Long term debt 53.20M - 806.56M 773.06M 534.29M
Inventory 3.20M 2.07M 0.15M - -
Accounts payable 70.21M 82.27M 71.07M 6.22M 3.98M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - 27.07M - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 60.76M 150.66M 62.53M 3.74M 2.89M
Deferred long term asset charges - - - - -
Non current assets total 2236.02M 2110.00M 1729.36M 1008.32M 625.58M
Capital lease obligations 11.78M - 2.29M 3.18M 6.19M
Long term debt total - - - - 537.48M
Breakdown 2025-02-28 2024-02-29 2023-02-28 2022-02-28 2021-02-28
Type yearly yearly yearly yearly yearly
Date 2025-02-28 2024-02-29 2023-02-28 2022-02-28 2021-02-28
Investments -99.93600M - -440.78100M -306.95600M -196.33800M
Change to liabilities - - - -2.66800M 14.17M
Total cashflows from investing activities -99.93600M - -440.78100M -306.95600M -196.33800M
Net borrowings -145.67100M - - - 213.76M
Total cash from financing activities -202.95600M 773.72M 470.93M 347.23M 213.76M
Change to operating activities - - - - -
Net income -246.92800M -110.27300M -36.43200M -42.30300M -50.79200M
Change in cash -442.75800M 415.37M -39.38300M -35.79000M -10.09400M
Begin period cash flow 471.07M 55.70M 95.09M 130.88M 140.97M
End period cash flow 28.32M 471.07M 55.70M 95.09M 130.88M
Total cash from operating activities -139.85400M -53.84700M -70.59600M -79.17500M -24.48600M
Issuance of capital stock 39.32M - 573.91M 113.11M 56.76M
Depreciation 62.56M 20.71M 5.41M 5.52M 4.74M
Other cashflows from investing activities 5.54M - 0.06M 0.00000M -10.05200M
Dividends paid - - - - -
Change to inventory -1.12500M -1.92600M -0.14700M 0.00000M -
Change to account receivables 14.73M -6.09500M -4.46200M -19.26300M -1.98500M
Sale purchase of stock 39.32M - 573.91M 113.11M 0.00000M
Other cashflows from financing activities -96.60100M 506.69M -46.87500M 265.40M 216.28M
Change to netincome - - - - 1.21M
Capital expenditures 132.12M 221.87M 440.84M 306.96M 186.29M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 6.17M -2.42100M 3.82M -21.93100M 12.19M
Stock based compensation 3.12M 8.07M 10.28M 3.12M 1.80M
Other non cash items 35.24M 30.07M -3.01600M 1.76M -2.57700M
Free cash flow -271.97700M -275.72100M -511.43200M -386.13100M -210.77200M

Peer Comparison

Sector: Energy Industry: Oil & Gas E&P

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
RLT
Renergen Ltd		 - -% - - 53.76 2.09 1.47 50.63 -4.3347
WDS
Woodside Energy Group Ltd		 -0.01 0.03% 31.04 11.12 27.55 4.54 1.17 3.84 5.32
STO
Santos Ltd		 0.04 0.53% 7.53 13.79 13.40 4.95 1.10 4.67 7.04
BPT
Beach Energy Ltd		 0.005 0.43% 1.16 - 6.63 1.26 0.83 1.48 5.91
KAR
Karoon Energy Ltd		 -0.14 7.07% 1.84 6.15 9.75 2.10 0.98 1.82 2.85

Reports Covered

Stock Research & News

View All

Profile

Renergen Limited, an investment holding company, engages in the alternative and renewable energy businesses in South Africa and sub-Saharan Africa. It operates through Tetra4 and Cryovation segments. The company explores for, develops, and sells liquefied natural gas and helium gas. It also develops Cryo-Vacc technology, which enables the transportation of vaccines and biologics at low temperature without any electrical power. Renergen Limited was founded in 2005 and is based in Sandton, South Africa. As of January 7, 2026, Renergen Limited operates as a subsidiary of ASP Isotopes Inc.

Renergen Ltd

Sandton Gate, Sandton, South Africa, 2196

Key Executives

Name Title Year Born
Mr. Stefano Marani MD, CEO & Exec. Director 1978
Mr. Brian Harvey BCom (Hons), BTech Mech, CA(SA) CFO & Director 1975
Mr. Nicholas Michael Mitchell COO & Exec. Director 1980
Mr. Johann H. J. Weideman Prescribed Officer NA
Mr. Khalid Patel Prescribed Officer NA
Mandy-Leigh Stuart Prescribed Officer NA
Nalanie Naidu Prescribed Officer NA
Mr. Muhammed Khan Prescribed Officer NA
Mr. Reginald Edmond Cooke Consultant 1975
Mr. Stefano Marani MD, CEO & Executive Director 1978

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.